Cas:785717-80-8 4,7-dimethoxy-6-methyl-2,3-dihydro-1H-inden-1-amine manufacturer & supplier

We serve Chemical Name:4,7-dimethoxy-6-methyl-2,3-dihydro-1H-inden-1-amine CAS:785717-80-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4,7-dimethoxy-6-methyl-2,3-dihydro-1H-inden-1-amine

Chemical Name:4,7-dimethoxy-6-methyl-2,3-dihydro-1H-inden-1-amine
CAS.NO:785717-80-8
Synonyms:2,3-DIHYDRO-4,7-DIMETHOXY-6-METHYL-1H-INDEN-1-AMINE;1H-Inden-1-amine,2,3-dihydro-4,7-dimethoxy-6-methyl
Molecular Formula:C12H17NO2
Molecular Weight:207.26900
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:44.48000
Exact Mass:207.12600
LogP:2.65850

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2,3-DIHYDRO-4,7-DIMETHOXY-6-METHYL-1H-INDEN-1-AMINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Inden-1-amine,2,3-dihydro-4,7-dimethoxy-6-methyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-DIHYDRO-4,7-DIMETHOXY-6-METHYL-1H-INDEN-1-AMINE Use and application,1H-Inden-1-amine,2,3-dihydro-4,7-dimethoxy-6-methyl technical grade,usp/ep/jp grade.


Related News: The ability of a CDMO to lay down good quality audits, knowledge of equipment, packaging configurations, and good capability building of resources, helps in determining a competent CDMO partner. β-Cyan-β-aci-nitro-acetaldehyd-anil manufacturers A major advantage of identifying suitable biocatalysts early on is that it provides ample opportunity for optimization. N-(3,5-bis(trifluoromethyl)benzyl)-1-(2-hydroxypropan-2-yl)-3-(((3S,4S)-3-methyltetrahydro-2H-pyran-4-yl)amino)cyclopentane-1-carboxamide suppliers Soliris would need a “substantial discount” to reach a more appropriate price, according to its report. Using the widely leveraged measure for disease burden known as quality-adjusted life year (QALY), ICER calculated a range of $6,900 to achieve $50,000 per QALY to $25,700 to hit $200,000 per QALY. 2-{2-[2-(5-bromo-2-methoxy-phenyl)-ethyl]-phenyl}-5-ethyl-1-methyl-4,5-dihydro-1H-imidazole vendor & factory.